The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2016
Filed:
May. 11, 2010
D. Laksen Sirimanne, Palo Alto, CA (US);
Natalie V. Fawzi, Belmont, CA (US);
Douglas S. Sutton, Pacifica, CA (US);
Gail S. Lebovic, Palo Alto, CA (US);
Stanley R. Conston, San Carlos, CA (US);
Peter M. Wilson, Foster City, CA (US);
Anne B. Morrissey, Menlo Park, CA (US);
Mary Elizabeth Bush, San Pedro, CA (US);
D. Laksen Sirimanne, Palo Alto, CA (US);
Natalie V. Fawzi, Belmont, CA (US);
Douglas S. Sutton, Pacifica, CA (US);
Gail S. Lebovic, Palo Alto, CA (US);
Stanley R. Conston, San Carlos, CA (US);
Peter M. Wilson, Foster City, CA (US);
Anne B. Morrissey, Menlo Park, CA (US);
Mary Elizabeth Bush, San Pedro, CA (US);
Devicor Medical Products, Inc., Sharonville, OH (US);
Abstract
Cavity and sentinel lymph node marking devices, marker delivery devices, and methods are disclosed. More particularly, upon insertion into a body, the cavity marking device and method enable one to determine the center, orientation, and periphery of the cavity by radiographic, mammography, echogenic, or other noninvasive imaging techniques. A composition and method are disclosed for locating the sentinel lymph node in a mammalian body to determine if cancerous cells have spread thereto. The composition is preferably a fluid composition consisting of a carrier fluid and some type of contrast agent; alternatively, the contrast agent may itself be a fluid and therefore not need a separate carrier fluid. This composition is capable of (1) deposition in or around a lesion and migration to and accumulation in the associated sentinel node, and (2) remote detection via any number of noninvasive techniques. Also disclosed is a method for remotely detecting the location of a sentinel node by (1) depositing a remotely detectable fluid in or around a lesion for migration to and accumulation in the associated sentinel node and (2) remotely detecting the location of that node with a minimum of trauma and toxicity to the patient. The composition and method may serve to mark a biopsy cavity, as well as mark the sentinel lymph node. The marking methods also may combine any of the features as described with the marking device and delivery device.